![]() ![]() Google Scholar, PubMed, Mendeley search engines were used for this purpose. We used 123 published manuscripts as our references. OCT-A has been utilized so far to describe abnormalities in multiple sclerosis (MS), Alzheimer's disease, arteritic and non-arteritic optic neuropathy (AION and NAION), Leber's hereditary optic neuropathy (LHON) papilloedema, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), Wolfram syndrome, migraines, lesions of the visual pathway and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). ![]() It appears that OCT-A findings correlate quite well with the severity of the aforementioned diseases. However, OCT-A has its own limitations, namely its lack of wide-field view of the peripheral retina and the inaccurate interpretation due to motion artifacts in uncooperative groups of patients (e.g. Larger prospective longitudinal studies will need to be conducted in order to eliminate the aforementioned limitations. Neuro-ophthalmology neurodegenerative diseases optical coherence tomography angiography. OCT angiography: an upcoming non-invasive tool for diagnosis of age-related macular degeneration. doi:10.1007/s4013-6īalaratnasingam C, Yannuzzi LA, Spaide RF. ![]() Possible choroidal neovacularization in macular telangiectasia type 2. Optical coherence tomography angiography in retinal vein occlusion: evaluation of superficial and deep capillary plexa. Wakabayashi T, Sato T, Hara-Ueno C, et al. Retinal microvasculature and visual acuity in eyes with branch retinal vein occlusion: imaging analysis by optical coherence tomography angiography. Volume-rendered optical coherence tomography of diabetic retinopathy pilot study. doi:10.1016/j.ajo.2015.09.To investigate the optical coherence tomography angiography (OCTA) characteristics of diabetic macular edema (DME) at different stages. Patients diagnosed with DME were recruited. DME was classified into early, advanced, and severe DME. ![]()
0 Comments
Leave a Reply. |